Pfizer Pulls Celebrex Advertising
157889
Description: Pfizer will stop advertising the painkiller Celebrex after discussions with the Food and Drug Administration. A study linked Celebrex to an increased risk of heart problems, but the company plans to keep it on the market.
422800
NEW YORK, December 30  - New prescriptions for pharmaceutical major Pfizerâs (PFE.NYS) arthritis drug Celebrex declined 56% last week after the company revealed that the regular usage of the drug could enhance the risk of heart attacks
106310
The US Food and Drug Administration is considering further regulatory measures, including withdrawal from the market, of Pfizer&#39;s arthritis treatment Celebrex.
34709
(CBS/AP) Vioxx, the blockbuster arthritis drug heavily promoted on TV and taken by tens of millions of people, was pulled from the market by its maker Thursday after a study found it doubled the risk of heart attacks and strokes.
643296
NEW YORK  - Drugs giant Pfizer Inc.&#39;s stock fell on a report that prescriptions for its blockbuster pain medication Celebrex slumped 56 percent last week.
176172
Pfizer Inc. said it would immediately stop advertising arthritis drug Celebrex to consumers after a study showed that high doses were associated with an increased risk of heart attacks, according to a published report.
85822
Pfizer plans to immediately stop advertising Celebrex, its best-selling arthritis pain reliever, to consumers after a study linked it to an increased risk of heart attacks.
108249
Pfizer reaffirmed its commitment today to Celebrex, its blockbuster prescription medication for pain and inflammation from arthritis, despite a disclosure last week that the drug had increased
238647
The arthritis drug Vioxx, used by millions of people around the world, is being pulled off the market after a study confirmed long-standing concerns that it raises the risk of heart attack and stroke, the manufacturer, Merck & Co. , said on Thursday.
764151
NEW YORK (Dow Jones/AP) -- Pfizer Inc. defended the safety of its painkiller Celebrex on Thursday after a newspaper reported that documents from Canadian health authorities linked the drug to the deaths of
259614
NEW YORK - Shares of pharmaceutical company Pfizer Inc. fell sharply in early trading after the firm reported an increased risk of heart disease for patients taking its Celebrex painkiller and arthritis drug.
224819
The U.S. Food and Drug Administration has warned Pfizer Inc.  that television and print advertisements for its painkillers Celebrex and Bextra misled consumers, according to a letter made public on Wednesday.
140168
Merck &amp; Co Inc. on Thursday pulled its arthritis drug Vioxx off the market because it increases the risk of heart attack and stroke, a move that sent the company&#39;s
693310
The Pfizer painkillers Celebrex and Bextra experienced a jump in sales immediately after rival Merck&#39;s Vioxx was pulled from the market in late September, but the gains appear to be short
484469
Pfizer Inc. shares rebounded on  Tuesday as a study of Alzheimer's patients found that its  arthritis drug Celebrex carried no increased cardiovascular  risks, differing from findings of a study in cancer patients  released last week.
114059
Pfizer Inc. said on Monday it plans to  sponsor a major clinical study to further assess the  cardiovascular safety of its arthritis drug Celebrex following  the withdrawal of Merck & Co.'s Vioxx, a drug in the same  class.
635918
No. 1 drugmaker to end marketing push after study points to higher risk of heart attack, stroke. NEW YORK (CNN) - Under pressure from regulators, Pfizer has agreed to limit advertising of Celebrex after a